SCHEMBL9766014

SCHEMBL9766014

O=C(CCCN1CCN(c2ncc(F)cn2)CC1)c1cccs1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.57
DRD2 P14416 2/20 0.57
ADRA2C P18825 1/20 0.57
DRD4 P21917 1/20 0.57
HTR2A P28223 1/20 0.57
HTR2C P28335 1/20 0.57
HRH1 P35367 1/20 0.57
DRD3 P35462 1/20 0.57
SIGMAR1 Q99720 6/20 0.53
TMEM97 Q5BJF2 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
GAA P10253 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246517 0.80 DRD2 (0.82) HTR1ADRD2ADRA2CDRD4HTR2A
SCHEMBL13562512 0.79 KMT2A (0.67) HTR1AHRH1MEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL9766015 0.79 DRD2 (0.80) HTR1ADRD2ADRA2CDRD4HTR2A
SCHEMBL9766005 0.79 HTR1A (0.50) HTR1ADRD2ADRA2CDRD4HTR2A
SCHEMBL9120363 0.78 KMT2A (0.83) HTR1AMEN1KMT2AALDH1A1MAPT
SCHEMBL10832835 0.78 HTR3A (0.51) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL9121163 0.77 KMT2A (0.81) HTR1AMEN1KMT2AALDH1A1MAPT
SCHEMBL9766055 0.76 SIGMAR1 (0.64) HTR1ADRD2ADRA2CDRD4HTR2A
SCHEMBL9141547 0.76 DRD2 (0.48) HTR1ADRD2ADRA2CDRD4HTR2A
Hydrochloric Acid SCHEMBL9120510 0.76 KMT2A (0.78) HTR1AMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US claimed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP claimed
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed